Importantly, we identified a large group of cancer types where low CREB3L1 expression is prevalent, including lung squamous cell carcinoma, melanoma and cancers of the kidney (clear cell), bladder, colon, liver, adrenal gland, rectum and cervix. Here, CREB3L1 is linked to cancer.